| Pharmaceutical active ingredients: |
| Erythromycin Ethylsuccinate |
| Available forms, composition and doses of Erythrolar: |
| Tablets; Oral; Erythromycin 250 mgTablets; Oral; Erythromycin 500 mg |
| Erythrolar medical category: |
| Human:Acne treatment preparationsAntibacterialsErythromycinsEye anti-infectives and antisepticsMacrolidesTopical antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01FA01 - ErythromycinS01AA17 - Erythromycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisLark Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Erythrocin Neo | Erythromycin Ethylsuccinate | Abbott |
| Erythro-ES | Erythromycin Ethylsuccinate | Pro Doc; AA Pharma |
| Erythroforte | Erythromycin Ethylsuccinate | Abbott |
| Erythrogram | Erythromycin Ethylsuccinate | Pharma 2000 Laboratoires |
| Erythrol | Erythromycin Ethylsuccinate | Vitamed Pharmaceutical Industries |
| Erythromycin | Erythromycin Ethylsuccinate | Dista |
| Erythromycin | Erythromycin Ethylsuccinate | Dr. August Wolff Arzneimittel |
| Erythromycin | Erythromycin Ethylsuccinate | Naska |
| Erythromycin | Erythromycin Ethylsuccinate | Parke-Davis |
| Erythromycin | Erythromycin Ethylsuccinate | Ratiopharm |